Triumvira Immunologics

Series-A
triumvira.com Biotech & Healthcare San Francisco, United States 11–50 employees
Total Funding $100M
Latest Round $45M Series-A
Last Announced Mar 17, 2022
Investors 10 Backers
Decision Makers 6 Available

About Triumvira Immunologics

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Team Size 11–50 employees
Tracked Since Nov 16, 2026

Web & Domain Identity

Official Website triumvira.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @Triumvirainc (57 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $45,000,000 · Series-A

    Backed by B Capital

  2. Capital Raise

    Raised $55,000,000 · Series-A

    Backed by Leaps by Bayer

Investors & Backers

10
B Capital
Lead
Leaps by Bayer
Lead
ATEM Capital Fund LP
Bloom Burton & Co.
Centre for Commercialization of Cancer Immunotherapy
Multiple Myeloma Research Foundation
Myeloma Investment Fund
Northpond Ventures
Oceanpine Capital
Viva Biotech

Funding History

2 Rounds
Series-A equity · Mar 17, 2022

Round backers: B Capital

Series-A equity · Aug 1, 2020

Round backers: Leaps by Bayer

Founders & Leadership

7

Andreas Bader

Chief Scientific Officer

Work email & phone locked Unlock →

Jonathan Bramson

Founder

Work email & phone locked Unlock →

Jon Irvin

Senior Vice President of Finance

Work email & phone locked Unlock →

Paul Lammers

President & CEO

Work email & phone locked Unlock →

Pedro Correa de Sampaio

Project Consultant

Work email & phone locked Unlock →

Robert Williamson

President and CBO

Work email & phone locked Unlock →

Sabine Chlosta

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts